Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Statement re. announcement

11 Jul 2008 13:05

RNS Number : 9056Y
Angle PLC
11 July 2008
 



ANGLE plc

11 July 2008

 

Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan or the Republic of Ireland

 

ANGLE plc ("ANGLE" or the "Company")

 

Statement re. announcement

The Board of ANGLE notes the announcement made today by Braveheart Investment Group plc ("Braveheart"). The Board continues to hold shareholder meetings to discuss its positive Preliminary Results announced yesterday. The Board will make a formal response as soon as reasonably practicable after due consideration. The Board considers that the Braveheart announcement contains a number of factual inaccuracies.

Ends

 

Contact:

 

Andrew Newland, Chief Executive

ANGLE plc

 

+ 44 (0) 1483 295830

 

 

 

Mark Connelly/ Stewart Wallace

Collins Stewart Europe Limited

 

+ 44 (0) 207 523 8350

 

Collins Stewart Europe Limited ("Collins Stewart") which is regulated in the United Kingdom by The Financial Services Authority is acting for the Company in relation to the matters described in this announcement and is not advising any other person, and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to customers of Collins Stewart or for providing advice in relation to the matters described in this announcement.

 

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of the Company, all "dealings" in any "relevant securities" of Braveheart or the Company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Braveheart or the Company, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Braveheart or the Company or by Braveheart or the Company or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk . 

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in price or securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPFFLFFVDBEBBV
Date   Source Headline
31st Mar 20063:54 pmRNSBoard Change
31st Mar 20063:52 pmRNSHolding(s) in Company
29th Mar 200611:45 amRNSEGM Statement
29th Mar 20067:02 amRNSNew Venture Company
6th Mar 20067:02 amRNSPlacing
24th Jan 20067:01 amRNSChange of Adviser
24th Jan 20067:01 amRNSInterim Results
24th Jan 20067:01 amRNSContract Extension
16th Dec 20052:32 pmRNSSnr Appt at Geomerics
17th Nov 20057:02 amRNSRe US Venture -- Aberro
15th Nov 20057:03 amRNSRe Synature Ltd
11th Nov 20057:29 amRNSAppointment at Novocellus Ltd
2nd Nov 20059:41 amRNSDirector/PDMR Shareholding
25th Oct 20058:00 amRNSAppointments - UK Ventures
20th Oct 20057:00 amRNSContract Extension
17th Oct 20057:01 amRNSVentures (US) Team Expansion
1st Sep 200512:43 pmRNSHolding(s) in Company
25th Aug 20053:02 pmRNSResult of AGM
11th Aug 20055:21 pmRNSAdditional Listing
1st Aug 20057:01 amRNSDirectorate Change
20th Jul 20058:30 amRNSContract Win
6th Jul 20057:01 amRNSFinal Results
24th Jun 20058:00 amRNSRe Provexis Admission to AIM
23rd Jun 20053:13 pmRNSNotice of Results
22nd Jun 200512:45 pmRNSHolding(s) in Company
10th Jun 20057:01 amRNSJoint Research Programme
31st May 20057:02 amRNSRe Acolyte Biomedica
26th May 20057:02 amRNSTrading Update
26th May 20057:02 amRNSProvexis - Reverse Takeover
6th May 20057:00 amRNSGeomerics - New Venture Co.
29th Apr 20057:01 amRNSNew US Venture
12th Apr 20057:00 amRNSNew Contracts
23rd Mar 200512:03 pmRNSRe Provexis Limited
21st Mar 20058:51 amRNSAdditional Listing
10th Mar 200512:06 pmRNSDirector Appt to UK Ventures
18th Feb 20058:52 amRNSProvexis Reverse Takeover
11th Feb 20057:00 amRNSNew Venture Company
10th Feb 20051:30 pmRNSHolding(s) in Company
20th Jan 20057:01 amRNSNew Agreement
20th Jan 20057:00 amRNSInterim Results
18th Jan 20057:00 amRNSLaunch of US Ventures
17th Jan 200510:47 amRNSAssociate Director Appointed
7th Jan 200510:44 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.